{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:37:11Z","timestamp":1761561431092,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","issue":"4-5","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroent\u00e9rologie Clinique et Biologique"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.gcb.2010.03.013","type":"journal-article","created":{"date-parts":[[2010,5,12]],"date-time":"2010-05-12T12:08:05Z","timestamp":1273666085000},"page":"239-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Triple therapy for patients with primary biliary cirrhosis with progressive disease despite ursodeoxycholic acid: Another step forward"],"prefix":"10.1016","volume":"34","author":[{"given":"M.M.","family":"Kaplan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.A.L.","family":"Bonis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gcb.2010.03.013_bib1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"AASLD Practice Guidelines: primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.gcb.2010.03.013_bib2","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/hep.22831","article-title":"Treatment with immunosupressives in patients with primary biliary cirrhosis who fail to respond to ursodiol","volume":"50","author":"Kaplan","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.gcb.2010.03.013_bib3","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22428","article-title":"Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis","volume":"48","author":"Corpechot","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.gcb.2010.03.013_bib4","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.cgh.2007.07.015","article-title":"Transplantation trends in primary biliary cirrhosis","volume":"5","author":"Lee","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gcb.2010.03.013_bib5","article-title":"Triple therapy with ursodeoxycholic acid, budesonide and mycophenolate mofetil in patients with features of severe PBC not responding to ursodeoxycholic acid alone","author":"Rabahi","year":"2010","journal-title":"Gastroenterol Clin Biol (Clin Res Hepatol Gastroenterol)"},{"key":"10.1016\/j.gcb.2010.03.013_bib6","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1111\/j.1572-0241.2000.02323.x","article-title":"Oral budesonide in the treatment of primary sclerosing cholangitis","volume":"95","author":"Angulo","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gcb.2010.03.013_bib7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1572-0241.2003.07182.x","article-title":"Efficacy of colchicine in patients with primary biliary cirrhosis poorly responsive to ursodiol and methotrexate","volume":"98","author":"Lee","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gcb.2010.03.013_bib8","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1365-2036.2006.03048.x","article-title":"Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy","volume":"24","author":"Babatin","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gcb.2010.03.013_bib9","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/gast.1999.0029900395","article-title":"Methotrexate in primary biliary cirrhosis unresponsive to ursodeoxycholic acid: an observational study in 10 patients","volume":"117","author":"Bonis","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gcb.2010.03.013_bib10","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s10620-009-0744-1","article-title":"Moexipril for Treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic Acid","volume":"55","author":"Charatcharoenwitthaya","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gcb.2010.03.013_bib11","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/00042737-199910000-00015","article-title":"Combination therapy with mycophenolate mofetil and ursodeoxycholic acid for primary biliary cirrhosis","volume":"11","author":"Jones","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.gcb.2010.03.013_bib12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/01.mcg.0000177230.13770.4e","article-title":"Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid","volume":"39","author":"Talwalkar","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.gcb.2010.03.013_bib13","first-page":"123","article-title":"Treatment of primary biliary cirrhosis with tetrathiomolybdate: results of a double-blind trial","volume":"155","author":"Askari","year":"2010","journal-title":"Transpl Res."},{"key":"10.1016\/j.gcb.2010.03.013_bib14","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1053\/jhep.2000.18663","article-title":"Silymarin in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid","volume":"32","author":"Angulo","year":"2000","journal-title":"Hepatology"}],"container-title":["Gastroent\u00e9rologie Clinique et Biologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399832010001259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399832010001259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:51:39Z","timestamp":1759974699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399832010001259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":14,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0399832010001259"],"URL":"https:\/\/doi.org\/10.1016\/j.gcb.2010.03.013","relation":{},"ISSN":["0399-8320"],"issn-type":[{"type":"print","value":"0399-8320"}],"subject":[],"published":{"date-parts":[[2010,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triple therapy for patients with primary biliary cirrhosis with progressive disease despite ursodeoxycholic acid: Another step forward","name":"articletitle","label":"Article Title"},{"value":"Gastroent\u00e9rologie Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gcb.2010.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}